Evidence map›Paper›PMID 38792673›Full record

ReviewMicroorganisms2024

Tackling the Antimicrobial Resistance "Pandemic" with Machine Learning Tools: A Summary of Available Evidence.

Doris Rusic, Marko Kumric, Ana Seselja Perisin, Dario Leskur, Josipa Bukic, Darko Modun, Marino Vilovic, Josip Vrdoljak, Dinko Martinovic, Marko Grahovac and 1 more

Abstract readReview
In one paragraph

Review in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Veterinary sciences · 2025
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Doris RusicDepartment of Pharmacy, University of Split School of Medicine, Soltanska 2A, 21000 Split, Croatia.ORCID 0000-0002-7018-4947
Marko KumricDepartment of Pathophysiology, University of Split School of Medicine, Soltanska 2A, 21000 Split, Croatia.ORCID 0000-0002-9696-3359
Ana Seselja PerisinDepartment of Pharmacy, University of Split School of Medicine, Soltanska 2A, 21000 Split, Croatia.ORCID 0000-0001-7927-5311
Dario LeskurDepartment of Pharmacy, University of Split School of Medicine, Soltanska 2A, 21000 Split, Croatia.ORCID 0000-0002-5126-3869
Josipa BukicDepartment of Pharmacy, University of Split School of Medicine, Soltanska 2A, 21000 Split, Croatia.ORCID 0000-0002-9316-5538
Darko ModunDepartment of Pharmacy, University of Split School of Medicine, Soltanska 2A, 21000 Split, Croatia.ORCID 0000-0001-9508-9383
Marino VilovicDepartment of Pathophysiology, University of Split School of Medicine, Soltanska 2A, 21000 Split, Croatia.ORCID 0000-0002-5433-5063
Josip VrdoljakDepartment of Pathophysiology, University of Split School of Medicine, Soltanska 2A, 21000 Split, Croatia.
Dinko MartinovicDepartment of Pathophysiology, University of Split School of Medicine, Soltanska 2A, 21000 Split, Croatia.ORCID 0000-0003-2060-5130
Marko GrahovacDepartment of Pharmacology, University of Split School of Medicine, Soltanska 2A, 21000 Split, Croatia.
Josko BozicDepartment of Pathophysiology, University of Split School of Medicine, Soltanska 2A, 21000 Split, Croatia.ORCID 0000-0003-1634-0635

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance is recognised as one of the top threats healthcare is bound to face in the future. There have been various attempts to preserve the efficacy of existing antimicrobials, develop new and efficient antimicrobials, manage infections with multi-drug resistant strains, and improve patient outcomes, resulting in a growing mass of routinely available data, including electronic health records and microbiological information that can be employed to develop individualised antimicrobial stewardship. Machine learning methods have been developed to predict antimicrobial resistance from whole-genome sequencing data, forecast medication susceptibility, recognise epidemic patterns for surveillance purposes, or propose new antibacterial treatments and accelerate scientific discovery. Unfortunately, there is an evident gap between the number of machine learning applications in science and the effective implementation of these systems. This narrative review highlights some of the outstanding opportunities that machine learning offers when applied in research related to antimicrobial resistance. In the future, machine learning tools may prove to be superbugs' kryptonite. This review aims to provide an overview of available publications to aid researchers that are looking to expand their work with new approaches and to acquaint them with the current application of machine learning techniques in this field.

Indexed as

antimicrobial resistanceartificial intelligencedrug discoverymachine learning

Identifiers

PMID38792673
PMCPMC11123121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.